| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |